Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Aratana Therapeutics, Inc. (NASDAQ:PETX.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PETX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TurbulentTime (68.78)
Submitted September 11, 2014

In the long run, PETX will see increasing revenue. For now, as of Sept 2014, it still doesn't have no real revenue yet as it is still in the process of getting drug approval.

asilverp (84.89)
Submitted August 29, 2014

price is 550 times sales. Looks like a classic story stock to me. Everyone loves pets. How could you go wrong with a stock that markets to them? Probably worth < 1$.

NASDAQ:PETX.DL VS S&P 500 (SPY)

NASDAQ:PETX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PETX.DL.

No one has written a Pitch for PETX.DL stock yet. Tell us why you think PETX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in PETX.DL.

No players have picked PETX.DL yet. Tell us why you think PETX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PETX.DL.